A Stepped Care Model of Adolescent Depression Treatment in Primary Care (SCIPT-A)
|ClinicalTrials.gov Identifier: NCT01443715|
Recruitment Status : Completed
First Posted : September 30, 2011
Last Update Posted : September 4, 2014
|Condition or disease||Intervention/treatment||Phase|
|Major Depressive Disorder Dysthymia||Behavioral: Stepped Care IPT-A (SCIPT-A) Behavioral: Treatment as Usual||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||48 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Stepped Care Model of Adolescent Depression Treatment in Primary Care|
|Study Start Date :||September 2011|
|Primary Completion Date :||June 2014|
|Study Completion Date :||July 2014|
Experimental: Stepped Care IPT-A - Interpersonal Psychotherapy
IPT-A focuses on communication and problem-solving skills.
Behavioral: Stepped Care IPT-A (SCIPT-A)
Interpersonal Psychotherapy for adolescents (IPT-A) is a guideline based treatment with established efficacy focusing on reducing depression symptoms and current interpersonal problems associated with depression.
Active Comparator: Treatment as Usual
Treatment as Usual is the standard treatment received in the community
Behavioral: Treatment as Usual
Standard treatment in the community
- Feasibility based on proportionality [ Time Frame: Up to 16 weeks ]The investigators will demonstrate the feasibility of the model by calculating the proportion of: 1) adolescent who attend SCIPT-A sessions, 2) adolescents stepped to Phase II who attend their pediatric appointments for medication management, 3) adolescents in Phase II who accepted and followed the medication treatment recommendation, 4) social workers' who were willing and able to learn the SCIPT-A model as demonstrated by displaying fidelity to the treatment model.
- The proportion of adolescents who agree to be randomized and enrolled in the study protocol [ Time Frame: Up to 16 weeks ]Acceptability of randomization will be determined by the proportion of adolescents from the total eligible who agree to be randomized and enrolled in the study protocol.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01443715
|United States, New York|
|New York State Psychiatric Institute|
|New York, New York, United States, 10032|
|Principal Investigator:||Laura Mufson, Ph.D.||Columbia University|